Form 4: Elanco Executive Modi Acquires Deferred Stock Units

Rajeev A. Modi, Executive Vice President at Elanco Animal Health Inc., acquired deferred stock units representing the right to receive company common stock.

Summary

• Rajeev A. Modi, Executive Vice President U.S. Pet Health and Global Digital Transformation for Elanco Animal Health Inc., acquired 64.7209 deferred stock units on April 3, 2026.
• These deferred stock units represent the right to receive one share of Elanco's common stock or its cash equivalent.
• The acquisition was made under a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
• Following this transaction, Modi beneficially owns 9,137.6387 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine executive stock transaction under a pre-arranged plan and does not provide new financial or strategic information.

Positives

• The transaction indicates continued investment and commitment from a key executive within Elanco Animal Health.
• The acquisition of deferred stock units aligns executive interests with shareholder value, as the units settle into common stock or cash equivalent.
• The transaction was made under a Rule 10b5-1(c) plan, suggesting a pre-arranged and structured approach to executive stock transactions, which can be viewed positively for governance.

Negatives

• The filing is a Form 4, which reports changes in beneficial ownership and does not inherently contain financial performance data or strategic updates that could be viewed as positive or negative in a broader business context.

Risks

• The value of the deferred stock units is subject to the future performance and stock price of Elanco Animal Health.
• Potential future sales of stock by executives, if not managed under 10b5-1 plans, could be perceived negatively by the market.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports a change in beneficial ownership.

Industry Context

StockSavvy.ai notes that executive stock unit acquisitions are common within the animal health industry as a method of compensation and aligning executive interests with long-term company performance. This type of filing is standard for reporting such transactions.

Stakeholder Impact

• Shareholders: The transaction may be viewed neutrally as it aligns executive interests with the company's stock performance through deferred compensation, but it does not provide new information about the company's operational or financial health.

Next Steps

• The deferred stock units will settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with the Executive Deferral and Stock Match Plan.

Key Dates

Keywords

Elanco Animal Health, ELAN, Form 4, Rajeev Modi, Deferred Stock Units, Beneficial Ownership, Executive Compensation, Insider Trading, Securities Exchange Act